Headache & Pain
Migraine: pathogenesis and pathophysiology
Nov. 18, 2022
Professor of Neurology
Director, Jefferson Headache Center
Thomas Jefferson University
Founding Editorial Board Member since 1994: Headache
Research and Clinical Interests: Headache, migraine, clinical trials
Contributor Disclosures
Dr. Silberstein, Director of the Jefferson Headache Center at Thomas Jefferson University, received consulting fees from Abbie, Curelator, Ipsen Therapeutics, Lundbeck Biopharmaceuticals, and Theranica for consulting. He is also the principal investigator for clinical trials conducted by Teva and Themaquil.